Drug Class
mineralocorticoid receptor antagonist
Type
brand
Active Ingredient
finerenone
📋Overview
Kerendia is a prescription medication containing finerenone, which is classified as a non-steroidal mineralocorticoid receptor antagonist. It is primarily associated with the management of chronic kidney disease in adults with type 2 diabetes. By targeting specific hormonal pathways, Kerendia helps address complications related to kidney and heart health in these populations. Its use reflects advances in therapies aimed at reducing the risk of disease progression and cardiovascular events.
📚References
Information from MedlinePlus.gov (NIH).
Found an Error?
Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.
Find Discounts for Kerendia
Hospitals.net Disclosure
Hospitals.net is an independent healthcare information platform and does not provide, administer, or guarantee prescription discounts, pricing, coupons, or pharmacy participation. All discount pricing and availability shown above are provided by RxGo and its partners and are subject to change without notice.
Hospitals.net may receive a commission or referral fee if you choose to use this prescription discount service. This does not affect the price you pay at the pharmacy. Hospitals.net is not responsible for pricing accuracy, pharmacy participation, or the fulfillment of any discount offers.